Regulation of Gene Expression and Cellular Processes in Eukaryotic Cells

Target Name: RPL27A

NCBI ID: G6157

Regulation of Gene Expression and Cellular Processes in Eukaryotic Cells

Ribosomal subunit protein uL15 (RPL27A) is a protein that plays a critical role in the regulation of gene expression in eukaryotic cells. It is a large protein that contains several functional domains, including a nucleotide-binding oligomerization domain (NBO), a domain for interaction with RNA-binding protein (RBP), and a domain for protein-protein interaction (PPI).

Expression and function

RPL27A is a highly expressed protein that is found in various cell types of the eukaryotic system, including the nucleus, mitochondria, and endoplasmic reticulum. It is a key component of the ribosome, the protein machine that synthesizes RNA in the cell.

One of the most important functions of RPL27A is its role in regulating gene expression. It interacts with various RNA-binding proteins, including RBP, to regulate the translation of mRNAs into the cytoplasm. RPL27A has been shown to interact with RBP and regulate the translation of specific genes.

In addition to its role in gene expression, RPL27A is also involved in the regulation of cellular processes such as cell growth, apoptosis, and autophagy. It has been shown to play a key role in the regulation of cell cycle progression, and is involved in the G1/S transition, G2/M transition, and G0/G1 transition.

Drug targeting

RPL27A is a potential drug target in the treatment of various diseases. One of the main reasons for its potential as a drug target is its involvement in the regulation of cellular processes that are often disrupted in diseases such as cancer, neurodegenerative diseases, and cardiovascular diseases.

For example, RPL27A has been shown to be involved in the regulation of cell cycle progression, which is often disrupted in cancer cells. It has been shown to inhibit the G1/S transition and promote the G2/M transition, which are critical steps in the cell cycle that are often activated. This suggests that RPL27A may be an effective inhibitor of cell cycle progression in cancer.

Another potential mechanism by which RPL27A may be targeted is its role in the regulation of apoptosis. RPL27A has been shown to play a key role in the regulation of apoptosis, which is a critical process that helps eliminate damaged or dysfunctional cells.

In addition to its involvement in apoptosis, RPL27A has also been shown to be involved in the regulation of cellular processes that are often disrupted in neurodegenerative diseases. For example, it has been shown to play a key role in the regulation of neurotransmitter synthesis and release , which is often disrupted in neurodegenerative diseases.

Conclusion

RPL27A is a protein that plays a critical role in the regulation of gene expression in eukaryotic cells. It is a large protein that contains several functional domains, including a nucleotide-binding oligomerization domain (NBO), a domain for interaction with RNA-binding protein ( RBP), and a domain for protein-protein interaction (PPI).

RPL27A is highly expressed in various cell types of the eukaryotic system and is involved in the regulation of cellular processes such as cell growth, apoptosis, and autophagy. It is a potential drug target in the treatment of various diseases due to its involvement in the regulation of cellular processes that are often disrupted in diseases.

Protein Name: Ribosomal Protein L27a

Functions: Component of the large ribosomal subunit (PubMed:23636399, PubMed:32669547). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399, PubMed:32669547)

More Common Targets